<?xml version="1.0" encoding="UTF-8"?>
<!-- generated by CLiX/Wiki2XML [MPI-Inf, MMCI@UdS] $LastChangedRevision: 92 $ on 16.04.2009 22:14:58[mciao0826] -->
<!DOCTYPE article SYSTEM "../article.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
<entity  confidence="0.9511911446218017" wordnetid="100001740">
<header>
<title>Lipid hypothesis</title>
<id>6176410</id>
<revision>
<id>243307992</id>
<timestamp>2008-10-06T00:11:25Z</timestamp>
<contributor>
<username>Lightbot</username>
<id>7178666</id>
</contributor>
</revision>
<categories>
<category>Angiology</category>
<category>Cardiovascular diseases</category>
</categories>
</header>
<bdy>

The <b>lipid hypothesis</b> was one of two <link xlink:type="simple" xlink:href="../281/14281.xml">
hypotheses</link> developed in the 1850s to explain the <link xlink:type="simple" xlink:href="../246/524246.xml">
pathogenesis</link> of <link xlink:type="simple" xlink:href="../385/85385.xml">
atherosclerosis</link>. It proposes a connection between <link xlink:type="simple" xlink:href="../715/14066715.xml">
plasma cholesterol level</link> and the development of <link xlink:type="simple" xlink:href="../735/5069735.xml">
coronary heart disease</link>. <p>

It was proposed by the German <link xlink:type="simple" xlink:href="../791/48791.xml">
pathologist</link> <link xlink:type="simple" xlink:href="../752/140752.xml">
Rudolph Virchow</link> in 1856 and suggested that blood <link xlink:type="simple" xlink:href="../940/17940.xml">
lipid</link> accumulation in arterial walls causes atherosclerosis.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%221%22])">1</ref> Since the emergence of <link xlink:type="simple" xlink:href="../662/512662.xml">
cardiovascular disease</link> as a major cause of death in the Western world in the middle of the 20th century, the lipid hypothesis received greater attention. An accumulation of evidence has led to the acceptance of the lipid hypothesis as scientific fact by the medical community;<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%222%22])">2</ref> however, a small but vocal minority contend that it has not yet been properly validated, and that vascular inflammatory mechanisms prevail independent of blood cholesterol levels.</p>

<sec>
<st>
The lipid hypothesis of atherogenesis</st>

<ss1>
<st>
Early studies and origin of the lipid hypothesis</st>
<p>

In 1913, a study by Nikolai Anitschkow showed that feeding rabbits <link xlink:type="simple" xlink:href="../437/6437.xml">
cholesterol</link> could induce symptoms similar to atherosclerosis, suggesting a role for cholesterol in atherogenesis.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%223%22])">3</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%224%22])">4</ref> In 1951, Duff and McMillian formulated the lipid hypothesis in its modern form in a review which appeared in the <it><link>
American Journal of Medicine</link></it>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%225%22])">5</ref> One of the most well known early modern proponents that <link xlink:type="simple" xlink:href="../746/264746.xml">
saturated fat</link>s and <link xlink:type="simple" xlink:href="../437/6437.xml">
cholesterol</link> in the blood are the cause of heart disease was <physical_entity wordnetid="100001930" confidence="0.8">
<person wordnetid="100007846" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<centenarian wordnetid="109904208" confidence="0.8">
<adult wordnetid="109605289" confidence="0.8">
<oldster wordnetid="110376523" confidence="0.8">
<link xlink:type="simple" xlink:href="../494/125494.xml">
Ancel Keys</link></oldster>
</adult>
</centenarian>
</causal_agent>
</person>
</physical_entity>
, whose first paper on the topic was published in 1953<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%226%22])">6</ref>, and whose book <it>Eat Well and Stay Well</it><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%227%22])">7</ref> helped the issue gain popular awareness.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%228%22])">8</ref></p>

</ss1>
<ss1>
<st>
Scientific consensus</st>
<p>

Since the middle of the 20th century, the lipid hypothesis proposing that <link xlink:type="simple" xlink:href="../746/264746.xml">
saturated fat</link>s and <link xlink:type="simple" xlink:href="../437/6437.xml">
cholesterol</link> in the blood are a major factor in cardiovascular disease has been the focus of research seeking to prove or disprove its validity. The interpretation of this research has resulted in the general acceptance of the lipid hypothesis as scientific fact by the end of the century.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%222%22])">2</ref> While it has attracted controversy, the <link xlink:type="simple" xlink:href="../727/423727.xml">
scientific consensus</link> was early on in its favor. A survey conducted in 1978 found that a large majority of researchers and practitioners were supportive of the validity of the lipid hypothesis.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%229%22])">9</ref> In this survey, 211 prominent researchers in the field were questioned about the association of the plasma cholesterol biomarker and the link of disease to diet. 90% responded with the following answers:
<table class="wikitable">
<row>
<header>
Question</header>
<header>
Yes</header>
<header>
No</header>
<header>
Uncertain</header>
</row>
<row>
<col>
Do you think there is a connection between plasma cholesterol level and the development of coronary heart disease?</col>
<col>
189</col>
<col>
2</col>
<col>
2</col>
</row>
<row>
<col>
Do you think that our knowledge about diet and coronary heart disease is sufficient to recommend a moderate change in the diet for the population of an affluent society?</col>
<col>
176</col>
<col>
16</col>
<col>
1</col>
</row>
</table>
</p>
<p>

The <link xlink:type="simple" xlink:href="../174/46174.xml">
National Institute of Health</link> held a consensus development conference reviewing the scientific evidence in 1984, during which a panel of 14 experts unanimously voted "yes" on the questions of whether blood cholesterol was causal and whether reducing it would help to prevent heart disease.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2210%22])">10</ref> The panel concluded:</p>
<p>

It has been established beyond a reasonable doubt that lowering definitely elevated blood cholesterol levels (specifically, blood levels of low-density lipoprotein (LDL) cholesterol) will reduce the risk of heart attacks caused by coronary heart disease...<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2211%22])">11</ref></p>


<p>

As of the end of the 1980s, the evidence accumulated through studies resulted in general acceptance of the lipid hypothesis and the rejection of the "cholesterol controversy",<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2212%22])">12</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2213%22])">13</ref> and by 2002, the lipid hypothesis was accepted by the scientific community as proven,<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2214%22])">14</ref> or, as one article stated, <it>"universally recognized as a law."</it><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2215%22])">15</ref> Critics point out that the standard for proof in the field is <link>
placebo controlled, double blind tests</link> and not <link xlink:type="simple" xlink:href="../943/742943.xml">
argumentum ad populum</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2216%22])">16</ref> A minority of the medical community still argue that the lipid hypothesis has not yet been scientifically validated as a cause of heart disease.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2217%22])">17</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2218%22])">18</ref>  </p>
<p>

Nowadays, the term "lipid hypothesis" is commonly used by the opponents of the <link xlink:type="simple" xlink:href="../727/423727.xml">
scientific consensus</link> concerning the role of <link xlink:type="simple" xlink:href="../437/6437.xml">
cholesterol</link> in <link xlink:type="simple" xlink:href="../385/85385.xml">
atherosclerosis</link> and <link xlink:type="simple" xlink:href="../662/512662.xml">
cardiovascular disease</link>, such as members of <link xlink:type="simple" xlink:href="../783/9018783.xml">
The International Network of Cholesterol Skeptics</link> founded in 2003 by critic <person wordnetid="100007846" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../621/8532621.xml">
Uffe Ravnskov</link></person>
.</p>

</ss1>
<ss1>
<st>
Controversy</st>

<ss2>
<st>
The cholesterol controversy of atherogenesis</st>
<p>

During the 70s and 80s, some researchers and practitioners considered the lipid hypothesis as unverified due to the lack of proof at that time that lowering blood cholesterol levels resulted in decreased risk for atherosclerosis.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2219%22])">19</ref> Some skeptics were questioning its validity by arguing that the studies supporting it were flawed.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2220%22])">20</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2221%22])">21</ref> This discussion is also referred to as the "cholesterol controversy." Predictions were made at the time that further research during the 1980s and 1990s would help settle this controversy.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2222%22])">22</ref> However, even after the Coronary Primary Prevention Trial and the NIH Consensus Conference in the mid 80s, criticism persisted in a minority of the <link xlink:type="simple" xlink:href="../705/338705.xml">
scientific community</link> questioning the statistical and mechanistic significance of the associations measured in the trials and the conclusions of the panel.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2223%22])">23</ref></p>
<p>

In the following years, studies with lipid- and cholesterol-lowering drugs such as <link xlink:type="simple" xlink:href="../197/178197.xml">
statin</link>s provided further associative evidence in support of the lipid hypothesis.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2224%22])">24</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2225%22])">25</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2226%22])">26</ref>  This was questioned on the basis that the positive effect of statins may be due to other effects than cholesterol-lowering - a meta-analysis of cholesterol-lowering trials demonstrated that coronary mortality was not lowered by cholesterol lowering, but total mortality was increased.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2227%22])">27</ref>  Further studies were designed in the hope of settling the controversy.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2228%22])">28</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2229%22])">29</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2230%22])">30</ref>  The continuing consensus regards the lipid hypothesis as proven; but disagreement still persists among a small group who argue that it is based on associations and misrepresented or overinterpreted data, and has not been shown as a scientifically validated causal mechanism.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2217%22])">17</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2231%22])">31</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2232%22])">32</ref></p>

</ss2>
<ss2>
<st>
Palm oil and blood cholesterol controversy</st>
<p>

<link xlink:type="simple" xlink:href="../561/57561.xml">
Palm oil</link> is a mix of about 50% saturated fatty acids (<link xlink:type="simple" xlink:href="../488/542488.xml">
palmitic acid</link>, <link xlink:type="simple" xlink:href="../511/338511.xml">
stearic acid</link>) with 50% unsaturated fatty acids (<link xlink:type="simple" xlink:href="../100/661100.xml">
oleic acid</link>, <link xlink:type="simple" xlink:href="../497/880497.xml">
linoleic acid</link>), supplemented with antioxidants, beta-carotene and vitamin E. While there is convincing evidence that palmitic and stearic acid contribute to an increased risk of developing cardiovascular diseases<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2233%22])">33</ref>, unsaturated fatty acids such as oleic and linoleic acid are effective in reducing serum total and low-density lipoprotein (LDL) cholesterol levels.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2234%22])">34</ref> Palm oil has a mixed effect: While consumption of palm oil leads to a higher blood cholesterol level compared to other vegetable oils, fresh palm oil leads to a reduction of endogenous cholesterol level and a reduced risk of arterial thrombosis and atherosclerosis.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2235%22])">35</ref> A study by a group of researchers in China comparing <link xlink:type="simple" xlink:href="../561/57561.xml">
palm</link>, <link>
soybean</link>, <link xlink:type="simple" xlink:href="../910/1195910.xml">
peanut oil</link>s and <link xlink:type="simple" xlink:href="../997/18621997.xml">
lard</link> showed that palm oil increased the levels of "good cholesterol" and reduced the levels of "bad cholesterol" in the blood.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2236%22])">36</ref> A study by Hornstra in 1990 also showed similar results.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2237%22])">37</ref> In contrast to fresh palm oil, oxidized (processed) palm oil has adverse effects on the lipid profile and contains toxic substances detrimental to health, e.g. by harming the liver.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2235%22])">35</ref></p>

</ss2>
</ss1>
</sec>
<sec>
<st>
Other lipid hypotheses</st>

<ss1>
<st>
The Alzheimer's lipid hypothesis and cholesterol controversy</st>
<p>

A new "cholesterol controversy" is emerging out of the research of the pathogenesis of <link xlink:type="simple" xlink:href="../017/18914017.xml">
Alzheimer's disease</link> (AD). A "lipid hypothesis of AD" has been proposed that suggests a connection between cholesterol and changes in brain lipids found in Alzheimer-type neuropathology.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2238%22])">38</ref></p>

</ss1>
<ss1>
<st>
The lipid hypothesis of osteoporosis</st>
<p>

The "lipid hypothesis of <link xlink:type="simple" xlink:href="../461/22461.xml">
osteoporosis</link>" postulates that lipids involved in causing heart disease also contribute to causing osteoporosis. Osteoporosis is characterized by a decrease of <link xlink:type="simple" xlink:href="../130/196130.xml">
bone marrow</link> cells, or <link xlink:type="simple" xlink:href="../986/419986.xml">
osteoblast</link>s, and an increase of fat cells, or <link xlink:type="simple" xlink:href="../229/625229.xml">
adipocyte</link>s. The formation of osteoblasts from preosteoblasts is reduced by oxidized lipids and in mice fed with a high fat diet. Observations from this model suggest that <link xlink:type="simple" xlink:href="../521/51521.xml">
LDL</link> oxidation products can cause osteoporosis through changing the developmental fate of bone cells leading to a reduced number of osteoblasts and increased numbers of fat cells.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2239%22])">39</ref></p>

</ss1>
<ss1>
<st>
The lipid hypothesis of cold tolerance</st>
<p>

In <link xlink:type="simple" xlink:href="../208/23208.xml">
plant</link>s and <link xlink:type="simple" xlink:href="../377/20377.xml">
microbe</link>s, changes in the lipid composition of <link xlink:type="simple" xlink:href="../481/7481.xml">
cell membrane</link>s have been linked to cold tolerance.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2240%22])">40</ref> The enhanced resistance to cold treatment appears to be caused by an increased amount of fatty acid desaturases produced under cold stress transforming saturated into unsaturated fatty acids in the membrane. This effect can be reproduced artificially in genetically engineered plants.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2241%22])">41</ref> The changes in membrane lipid composition lead to a higher membrane fluidity, thus keeping the membrane from "freezing" at low temperatures. This "lipid hypothesis of cold tolerance" is less well supported in animals. In <link xlink:type="simple" xlink:href="../032/9032.xml">
fruit flies</link>, cold acclimation does not coincide with a reduced amount of saturated fatty acids,<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2242%22])">42</ref> and recent genetic studies on a <link xlink:type="simple" xlink:href="../534/57534.xml">
nematode</link> indicate that the mechanisms involved in cold adaptation in animals may be different from those in plants and microbes.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2243%22])">43</ref></p>

</ss1>
</sec>
<sec>
<st>
 See also </st>
<p>

<list>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../385/85385.xml">
Atherosclerosis</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../437/6437.xml">
Cholesterol</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../039/513039.xml">
Hypercholesterolemia</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../715/14066715.xml">
Blood lipids</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../783/9018783.xml">
The International Network of Cholesterol Skeptics</link></entry>
<entry level="1" type="bullet">

<substance wordnetid="100020090" confidence="0.8">
<diet wordnetid="107561112" confidence="0.8">
<food wordnetid="100021265" confidence="0.8">
<fare wordnetid="107560652" confidence="0.8">
<link xlink:type="simple" xlink:href="../528/8095528.xml">
Medical research related to low-carbohydrate diets</link></fare>
</food>
</diet>
</substance>
</entry>
</list>
</p>

</sec>
<sec>
<st>
 Notes and references </st>

<p>

<reflist>
<entry id="1">
 <cite style="font-style:normal" class="book">Virchow, Rudolph&#32;(1856). Phlogose und Thrombose im Gefässystem. In: Gesammelte Abhandlungen zur wissenschaftlichen Medizin.&#32;Germany:&#32;Staatsdruckerei Frankfurt.</cite>&nbsp;</entry>
<entry id="2">
 <cite style="font-style:normal">Steinberg D&#32;(2006).&#32;"Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversy". <it>J. Lipid Res.</it>&#32;<b>47</b>&#32;(7): 1339–51. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1194%2Fjlr.R600009-JLR200">
10.1194/jlr.R600009-JLR200</weblink>. PMID 16585781.</cite>&nbsp;</entry>
<entry id="3">
 <cite style="font-style:normal">Anitschkow NN, Chatalov S&#32;(1913).&#32;"Über experimentelle Cholesterinsteatose und ihre Bedeutung für die Entstehung einiger pathologischer Prozesse". <it>Zentralbl Allg Pathol</it>&#32;<b>24</b>: 1–9.</cite>&nbsp;</entry>
<entry id="4">
 <cite style="font-style:normal">Anitschkow NN&#32;(1913).&#32;"Über die Veränderungen der Kaninchenaorta bei experimenteller Cholesterinsteatose". <it>Beitr Pathol Anat</it>&#32;<b>56</b>: 379–404.</cite>&nbsp;</entry>
<entry id="5">
 <cite style="font-style:normal">Duff GL, McMillian GC&#32;(1951).&#32;"Pathology of atherosclerosis". <it>Am J Med</it>&#32;<b>11</b>: 92–108. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2F0002-9343%2851%2990011-3">
10.1016/0002-9343(51)90011-3</weblink>.</cite>&nbsp;</entry>
<entry id="6">
 <cite style="font-style:normal">Keys A&#32;(1953).&#32;"Atherosclerosis: a problem in newer public health". <it>Journal of the Mount Sinai Hospital, New York</it>&#32;<b>20</b>&#32;(2): 118–39. PMID 13085148.</cite>&nbsp;</entry>
<entry id="7">
 <cite style="font-style:normal" class="book">Keys, Ancel&#32;(1959). Eat Well and Stay Well.&#32;United States:&#32;Doubleday. ISBN 0385065752.</cite>&nbsp;</entry>
<entry id="8">
"<weblink xlink:type="simple" xlink:href="http://www.the-aps.org/membership/obituaries/ancel_keys.htm">
Ancel Keys Obituary</weblink>".&#32;  The American Physiological Society.&#32;Retrieved on <link>
2007-04-15</link>.</entry>
<entry id="9">
 <cite style="font-style:normal">Norum KR&#32;(1978).&#32;"Some present concepts concerning diet and prevention of coronary heart disease.". <it>Nutr Metab</it>&#32;<b>22</b>: 1–7. PMID 619310.</cite>&nbsp;</entry>
<entry id="10">
 <cite style="font-style:normal">Steinberg D&#32;(2006).&#32;"An interpretive history of the cholesterol controversy, part IV: The 1984 coronary primary prevention trial ends it - almost". <it>J Lipid Res</it>&#32;<b>47</b>: 1–14. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1194%2Fjlr.R500014-JLR200">
10.1194/jlr.R500014-JLR200</weblink>. PMID 16227628.</cite>&nbsp;</entry>
<entry id="11">
from NIH Consensus Development Conference, JAMA 1985, 253:2080</entry>
<entry id="12">
 <cite style="font-style:normal">Steinberg D&#32;(1989).&#32;"The cholesterol controversy is over. Why did it take so long?". <it>Circulation</it>&#32;<b>80</b>: 1070–1078. PMID 2676235.</cite>&nbsp;</entry>
<entry id="13">
 <cite style="font-style:normal">LaRosa JC&#32;(1998).&#32;"Cholesterol &amp; atherosclerosis: a controversy resolved". <it>Adv Nurse Pract</it>&#32;<b>6</b>: 36–37. PMID 9633288.</cite>&nbsp;</entry>
<entry id="14">
 <cite style="font-style:normal">Steinberg D&#32;(2002).&#32;"Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime". <it>Nature Medicine</it>&#32;<b>8</b>: 1211–1217. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1038%2Fnm1102-1211">
10.1038/nm1102-1211</weblink>. PMID 12411947.</cite>&nbsp;</entry>
<entry id="15">
 <cite style="font-style:normal">Thompson GR, Packard CJ, Stone NJ&#32;(2002).&#32;"Goals of statin therapy: three viewpoints". <it>Curr Atheroscler Rep</it>&#32;<b>4</b>: 26–33. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1007%2Fs11883-002-0059-6">
10.1007/s11883-002-0059-6</weblink>. PMID 11772419.</cite>&nbsp;</entry>
<entry id="17">
 <cite style="font-style:normal" class="book">Ravenskov, Uffe&#32;(2000). The cholesterol myths.&#32;Washington, DC:&#32;New Trends Publishing. ISBN 0-96708987-0-0.</cite>&nbsp;</entry>
<entry id="16">
 <cite style="font-style:normal" class="book">Taubes, Gary&#32;(2007). Good Calories, Bad Calories.&#32;United States:&#32;Knoph. ISBN 1400040787.</cite>&nbsp;</entry>
<entry id="19">
 <cite style="font-style:normal">Rifkind B, Levy R&#32;(1978).&#32;"Testing the lipid hypothesis. Clinical trials". <it>Archives of surgery (Chicago, Ill. : 1960)</it>&#32;<b>113</b>&#32;(1): 80–3. PMID 619863.</cite>&nbsp;</entry>
<entry id="18">
"<weblink xlink:type="simple" xlink:href="http://www.thincs.org">
THINCS home page</weblink>".&#32;  <link xlink:type="simple" xlink:href="../783/9018783.xml">
The International Network of Cholesterol Skeptics</link>.&#32;Retrieved on <link>
2007-04-15</link>.</entry>
<entry id="21">
 <cite style="font-style:normal">Stehbens W&#32;(1988).&#32;"Flaws in the lipid hypothesis of atherogenesis". <it>Pathology</it>&#32;<b>20</b>&#32;(4): 395–6. PMID 3241740.</cite>&nbsp;</entry>
<entry id="20">
 <cite style="font-style:normal">Oliver M&#32;(1981).&#32;"Lipid lowering and ischaemic heart disease". <it>Acta Med. Scand. Suppl.</it>&#32;<b>651</b>: 285–93. PMID 6948505.</cite>&nbsp;</entry>
<entry id="23">
 <cite style="font-style:normal">Kolata G&#32;(1985).&#32;"Heart panel's conclusions questioned". <it>Science</it>&#32;<b>227</b>&#32;(4682): 40–1. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1126%2Fscience.3880617">
10.1126/science.3880617</weblink>. PMID 3880617.</cite>&nbsp;</entry>
<entry id="22">
 <cite style="font-style:normal">Gotto AM Jr&#32;(1984).&#32;"Directions of atherosclerosis research in the 1980s and 1990s". <it>Circulation</it>&#32;<b>70</b>: III88–94. PMID 6488509.</cite>&nbsp;</entry>
<entry id="25">
 <cite style="font-style:normal">Brown WV&#32;(1990).&#32;"Review of clinical trials: proving the lipid hypothesis". <it>Eur Heart J</it>&#32;<b>11 Suppl H</b>: 15–20. PMID 2073909.</cite>&nbsp;</entry>
<entry id="24">
 <cite style="font-style:normal">Tyroler HA&#32;(1987).&#32;"Review of lipid-lowering clinical trials in relation to observational epidemiologic studies". <it>Circulation</it>&#32;<b>76</b>: 515–522. PMID 3304704.</cite>&nbsp;</entry>
<entry id="27">
 <cite style="font-style:normal">Ravnskov Uffe&#32;(1992).&#32;"Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome". <it>British Medical Journal</it>&#32;<b>305</b>: 15–19, 420–422, 717.</cite>&nbsp;</entry>
<entry id="26">
 <cite style="font-style:normal">Kroon AA, Stalenhoef AF&#32;(1997).&#32;"LDL-cholesterol lowering and atherosclerosis -- clinical benefit and possible mechanisms: an update". <it>Neth J Med</it>&#32;<b>51</b>: 16–27. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2FS0300-2977%2897%2900031-4">
10.1016/S0300-2977(97)00031-4</weblink>. PMID 9260486.</cite>&nbsp;</entry>
<entry id="29">
 <cite style="font-style:normal">Steiner G&#32;(1996).&#32;"The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the <organization wordnetid="108008335" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../583/33583.xml">
World Health Organization</link></organization>
". <it>Diabetologia</it>&#32;<b>39</b>: 1655–1661. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1007%2Fs001250050630">
10.1007/s001250050630</weblink>. PMID 9081851.</cite>&nbsp;</entry>
<entry id="28">
 <cite style="font-style:normal">Pyrola K, Steiner G&#32;(1996).&#32;"Will correction of dyslipoproteinaemia reduce coronary heart disease risk in patients with non-insulin-dependent diabetes? Need for trial evidence". <it>Ann Med</it>&#32;<b>28</b>: 357–362. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.3109%2F07853899608999093">
10.3109/07853899608999093</weblink>. PMID 8862691.</cite>&nbsp;</entry>
<entry id="31">
 <cite style="font-style:normal">Stehbens WE&#32;(2001).&#32;"Coronary heart disease, hypercholesterolemia, and atherosclerosis I. False premises". <it>Exp Mol Pathol</it>&#32;<b>70</b>: 103–119. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1006%2Fexmp.2000.2340">
10.1006/exmp.2000.2340</weblink>. PMID 11263954.</cite>&nbsp;</entry>
<entry id="30">
 <cite style="font-style:normal">Steiner G&#32;(2000).&#32;"Lipid intervention trials in diabetes". <it>Diabetes Care</it>&#32;<b>23 Suppl 2</b>: B49–53. PMID 10860191.</cite>&nbsp;</entry>
<entry id="34">
 <cite style="font-style:normal">Vessby B&#32;(1994).&#32;"Implications of long-chain fatty acid studies". <it>INFORM</it>&#32;<b>5</b>: 182–185.</cite>&nbsp;</entry>
<entry id="35">
 <cite style="font-style:normal">Edem D&#32;(2002).&#32;"Palm oil: biochemical, physiological, nutritional, hematological, and toxicological aspects: a review". <it>Plant foods for human nutrition (Dordrecht, Netherlands)</it>&#32;<b>57</b>&#32;(3-4): 319–41. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1023%2FA%3A1021828132707">
10.1023/A:1021828132707</weblink>. PMID 12602939.</cite>&nbsp;</entry>
<entry id="32">
 <cite style="font-style:normal">Stehbens WE&#32;(2001).&#32;"Coronary heart disease, hypercholesterolemia, and atherosclerosis II. Misrepresented data". <it>Exp Mol Pathol</it>&#32;<b>70</b>: 120–139. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1006%2Fexmp.2000.2339">
10.1006/exmp.2000.2339</weblink>. PMID 11263955.</cite>&nbsp;</entry>
<entry id="33">
"<weblink xlink:type="simple" xlink:href="http://www.fao.org/DOCREP/005/AC911E/ac911e00.htm">
Diet, Nutrition and the Prevention of Chronic Diseases</weblink>".&#32;  World Health Organization.&#32;Retrieved on <link>
2007-04-18</link>. - <weblink xlink:type="simple" xlink:href="http://www.who.int/hpr/NPH/docs/who_fao_expert_report.pdf">
PDF</weblink> (WHO Technical Report Series 916. Geneva. 2003. pages 82, 88 &amp;c)</entry>
<entry id="38">
 <cite style="font-style:normal">Kivipelto M, Solomon A, Blennow K, Olsson AG, Winblad B&#32;(2006).&#32;"The new cholesterol controversy - a little bit of history repeating?". <it>Acta Neurol Scand</it>&#32;<b>114 Suppl 185</b>: 1–2. PMID 16866903.</cite>&nbsp;</entry>
<entry id="39">
 <cite style="font-style:normal">Parhami F, Jackson SM, Tintut Y, Le V, Balucan JP, Territo M, Demer LL&#32;(1999).&#32;"Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells". <it>J. Bone Miner. Res.</it>&#32;<b>14</b>&#32;(12): 2067–78. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1359%2Fjbmr.1999.14.12.2067">
10.1359/jbmr.1999.14.12.2067</weblink>. PMID 10620066.</cite>&nbsp;</entry>
<entry id="36">
 <cite style="font-style:normal">Zhang J, Ping W, Chunrong W, Shou C, Keyou G&#32;(1997).&#32;"Nonhypercholesterolemic effects of a palm oil diet in Chinese adults". <it>J. Nutr.</it>&#32;<b>127</b>&#32;(3): 509S–513S. PMID 9082037.</cite>&nbsp;</entry>
<entry id="37">
 <cite style="font-style:normal">Hornstra G, van Houwelingen A, Kester A, Sundram K&#32;(1991).&#32;"A palm oil-enriched diet lowers serum lipoprotein(a) in normocholesterolemic volunteers". <it>Atherosclerosis</it>&#32;<b>90</b>&#32;(1): 91–3. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2F0021-9150%2891%2990247-Z">
10.1016/0021-9150(91)90247-Z</weblink>. PMID 1839208.</cite>&nbsp;</entry>
<entry id="42">
 <cite style="font-style:normal">Ohtsu T, Kimura M, Katagiri C&#32;(1998).&#32;"How Drosophila species acquire cold tolerance--qualitative changes of phospholipids". <it>Eur. J. Biochem.</it>&#32;<b>252</b>&#32;(3): 608–11. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1046%2Fj.1432-1327.1998.2520608.x">
10.1046/j.1432-1327.1998.2520608.x</weblink>. PMID 9546680.</cite>&nbsp;</entry>
<entry id="43">
 <cite style="font-style:normal">Hayward S, Murray P, Gracey A, Cossins A&#32;(2007).&#32;"Beyond the lipid hypothesis: mechanisms underlying phenotypic plasticity in inducible cold tolerance". <it>Adv. Exp. Med. Biol.</it>&#32;<b>594</b>: 132–42. PMID 17205681.</cite>&nbsp;</entry>
<entry id="40">
 <cite style="font-style:normal">Finegold L&#32;(1986).&#32;"Molecular aspects of adaptation to extreme cold environments". <it>Adv Space Res</it>&#32;<b>6</b>&#32;(12): 257–64. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2F0273-1177%2886%2990094-3">
10.1016/0273-1177(86)90094-3</weblink>. PMID 11537829.</cite>&nbsp;</entry>
<entry id="41">
 <cite style="font-style:normal">Kodama, Kodama, Kodama, Kodama, Kodama&#32;(1994).&#32;"Genetic Enhancement of Cold Tolerance by Expression of a Gene for Chloroplast [omega]-3 Fatty Acid Desaturase in Transgenic Tobacco"&#32;<b>105</b>&#32;(2): 601–605. PMID 12232227.</cite>&nbsp;</entry>
</reflist>
</p>

</sec>
<sec>
<st>
 External links </st>
<p>

<list>
<entry level="1" type="bullet">

 A 5-part history of the lipid hypothesis and the "cholesterol controversy" by Daniel Steinberg, published in the <it>Journal of Lipid Research</it> in 2004&ndash;2006. These are condensed from his <it>The Cholesterol Wars</it>. Academic Press, 2007. ISBN 0-12373-979-9.</entry>
<entry level="2" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.jlr.org/cgi/content/full/45/9/1583">
An interpretive history of the cholesterol controversy: part I</weblink>. PMID 15102877.</entry>
<entry level="2" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.jlr.org/cgi/content/full/46/2/179">
An interpretive history of the cholesterol controversy: part II: the early evidence linking hypercholesterolemia to coronary disease in humans</weblink>. PMID 15547293.</entry>
<entry level="2" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.jlr.org/cgi/content/full/46/10/2037">
An interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia</weblink>. PMID 15995167.</entry>
<entry level="2" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.jlr.org/cgi/content/full/47/1/1">
An interpretive history of the cholesterol controversy, part IV: The 1984 Coronary Primary Prevention Trial ends it—almost</weblink>. PMID 16227628.</entry>
<entry level="2" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.jlr.org/cgi/content/full/47/7/1339">
An interpretive history of the cholesterol controversy, part V: The discovery of the statins and the end of the controversy</weblink>. PMID 16585781.</entry>
</list>
</p>

</sec>
</bdy>
</entity>
</article>
